Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Marcos, Veronica ^a   Latzin, Phillip ^b   Hector, Andreas ^a   Sonanini, Sebastian ^d   Hoffmann, Florian ^a   Lacher, Martin ^a   Koller, Barbara ^c   Bufler, Philip ^a   Nicolai, Thomas ^a   Hartl, Dominik ^a   Griese, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d Klinikum Harlaching   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MEMBRANE ASSOCIATED CD14 PROTEIN; MEMBRANE PROTEIN; SERINE PROTEINASE; SOLUBLE CD14 RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; CD14 ANTIGEN;

ALLERGIC ASTHMA; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; CYSTIC FIBROSIS; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MONOCYTE; PERIPHERAL BLOOD MACROPHAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SCHOOL CHILD; CELL MEMBRANE; GENE EXPRESSION REGULATION; METABOLISM; PNEUMONIA; SOLUBILITY;

ANTIGENS, CD14; CELL MEMBRANE; CHILD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; PNEUMONIA; SOLUBILITY;

EID: 77952485486     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-32     Document Type: Article

References (36)

1. Colin AA. Pneumonia in the developed world 18. Paediatr Respir Rev 2006, 7(Suppl 1):S138-S140. 10.1016/j.prrv.2006.04.181, 16798541.
2. Zar HJ, Madhi SA. Childhood pneumonia--progress andchallenges 4. S Afr Med J 2006, 96(9 Pt 2):890-900.
3. Schutt C. CD14. Int J Biochem Cell Biol 1999, 31(5):545-9. 10.1016/S1357-2725(98)00153-8, 10399315.
4. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249(4975):1431-3. 10.1126/science.1698311, 1698311.
5. Schutt C, Schilling T, Kruger C. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes. Allerg Immunol (Leipz) 1991, 37(3-4):159-64.
6. Dentener MA, Bazil V, Vonasmuth EJU, Ceska M, Buurman WA. Involvement of Cd14 in Lipopolysaccharide-Induced Tumor-Necrosis-Factor-Alpha, Il-6 and Il-8 Release by Human Monocytes and Alveolar Macrophages. Journal of Immunology 1993, 150(7):2885-91.
7. Kielian TL, Blecha F. CD14 and other recognition moleculesfor lipopolysaccharide: a review. Immunopharmacology 1995, 29(3):187-205. 10.1016/0162-3109(95)00003-C, 7542643.
8. Wright SD. CD14 and innate recognition of bacteria. J Immunol 1995, 155(1):6-8.
9. Stelter F, Pfister M, Bernheiden M, et al. The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contributionof N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem 1996, 236(2):457-64. 10.1111/j.1432-1033.1996.00457.x, 8612616.
10. Bufler P, Stiegler G, Schuchmann M, et al. Soluble lipopolysaccharide receptor (CD14) is released via two differentmechanisms from human monocytes and CD14 transfectants. EurJ Immunol 1995, 25(2):604-10.
11. Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide binding protein, and thealveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155(3):937-44.
12. Dessing MC, Knapp S, Florquin S, de Vos AF, van der PT. CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus Pneumoniae. Am J Respir Crit Care Med 2006,
13. Shwachman H, Kulczycki LL. Long-Term Study of 105 Patients with Cystic Fibrosis. Ama Journal of Diseases of Children 1958, 96(1):6-15.
14. [Anon] Standardization of Spirometry - 1994 Update. American Journal of Respiratory and Critical Care Medicine 1995, 152(3):1107-36. [Anon].
15. Griese M, Felber J, Reiter K, et al. Airway inflammation in children with tracheostomy. Pediatr Pulmonol 2004, 37:356-61. 10.1002/ppul.10432, 15022133.
16. Hartl D, Griese M, Nicolai T, et al. Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J Allergy Clin Immunol 2005, 115(4):728-36. 10.1016/j.jaci.2004.11.049, 15805991.
17. Griese M, Ramakers J, Krasselt A, et al. Improvement ofalveolar glutathione and lung function but not oxidative state incystic fibrosis. Am J Respir Crit Care Med 2004, 169(7):822-8. 10.1164/rccm.200308-1104OC, 14726422.
18. Ratjen F, Rietschel E, Griese M, et al. Fractionalanalysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for theevaluation of anti-inflammatory treatment (BEAT) study group. Eur Respir J 2000, 15(1):141-5. 10.1183/09031936.00.15114100, 10678636.
19. Griese M, Latzin P, Kappler M, et al. Alpha-1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2006,
20. Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. AmJ Respir Crit Care Med 1995, 151(2 Pt 1):544-7.
21. Landmann R, Knopf H, Link S, Sansano S, Schumann R, Zimmerli W. Human Monocyte CD14 Is Upregulated by Lipopolysaccharide. Infection and Immunity 1996, 64:1762-9. 173990, 8613389.
22. Motulsky H. Intuitive biostatistics. 1995, New York: Oxford University Press.
23. Ward C, Walters EH, Zheng L, Whitford H, Williams TJ, Snell GI. Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients. Eur Respir J 2002, 19(3):472-8. 10.1183/09031936.02.00225502, 11936525.
24. Landmann R, Zimmerli W, Sansano S, et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 1995, 171(3):639-44.
25. Burgmann H, Winkler S, Locker GJ, et al. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin Immunol Immunopathol 1996, 80(3 Pt 1):307-10. 10.1006/clin.1996.0128, 8811052.
26. Almirall J, Bolibar I, Toran P, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004, 125(4):1335-42. 10.1378/chest.125.4.1335, 15078743.
27. Garcia VE, Martinez JA, Mensa J, et al. C-reactive protein levels in community-acquired pneumonia. Eur Respir J 2003, 21(4):702-5. 10.1183/09031936.03.00080203, 12762360.
28. Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997, 10(5):1125-9. 10.1183/09031936.97.10051125, 9163657.
29. Requejo HI, Cocoza AM. C-reactive protein in thediagnosis of community-acquired pneumonia. Braz J Infect Dis 2003, 7(4):241-4. 10.1590/S1413-86702003000400003, 14533984.
30. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995, 108(5):1288-91. 10.1378/chest.108.5.1288, 7587431.
31. Heiskanen-Kosma T, Korppi M. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings. Scand J Infect Dis 2000, 32(4):399-402. 10.1080/003655400750044971, 10959648.
32. Alexis NE, Muhlebach MS, Peden DB, Noah TL. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J Cyst Fibros 2006, 5(1):17-25. 1764441, 16356787.
33. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti AG. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 2005, 25(4):647-52. 10.1183/09031936.05.00062304, 15802338.
34. Haugen TS, Nakstad B, Skjonsberg OH, Lyberg T. CD14 expression and binding of lipopolysaccharide to alveolar macrophages and monocytes. Inflammation 1998, 22(5):521-32. 10.1023/A:1022302228051, 9793798.
35. Bas S, Gauthier B, Spenato U, Stingelin S, Gabay C. CD14 is a acute-phase protein. J Immunol 2006, 172:4470-9.
36. Le Barillec K, Si-Tahar M, Balloy V, Chignard M. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J Clin Invest 1999, 103(7):1039-46. 10.1172/JCI5779, 408261, 10194477.